Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun 4;459(7247):717-21.
doi: 10.1038/nature07968. Epub 2009 May 3.

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma

Mara Compagno  1 , Wei Keat Lim, Adina Grunn, Subhadra V Nandula, Manisha Brahmachary, Qiong Shen, Francesco Bertoni, Maurilio Ponzoni, Marta Scandurra, Andrea Califano, Govind Bhagat, Amy Chadburn, Riccardo Dalla-Favera, Laura Pasqualucci
Affiliations

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma

Mara Compagno et al. Nature. .

Abstract

Diffuse large B-cell lymphoma (DLBCL), the most common form of lymphoma in adulthood, comprises multiple biologically and clinically distinct subtypes including germinal centre B-cell-like (GCB) and activated B-cell-like (ABC) DLBCL. Gene expression profile studies have shown that its most aggressive subtype, ABC-DLBCL, is associated with constitutive activation of the NF-kappaB transcription complex. However, except for a small fraction of cases, it remains unclear whether NF-kappaB activation in these tumours represents an intrinsic program of the tumour cell of origin or a pathogenetic event. Here we show that >50% of ABC-DLBCL and a smaller fraction of GCB-DLBCL carry somatic mutations in multiple genes, including negative (TNFAIP3, also called A20) and positive (CARD11, TRAF2, TRAF5, MAP3K7 (TAK1) and TNFRSF11A (RANK)) regulators of NF-kappaB. Of these, the A20 gene, which encodes a ubiquitin-modifying enzyme involved in termination of NF-kappaB responses, is most commonly affected, with approximately 30% of patients displaying biallelic inactivation by mutations and/or deletions. When reintroduced in cell lines carrying biallelic inactivation of the gene, A20 induced apoptosis and cell growth arrest, indicating a tumour suppressor role. Less frequently, missense mutations of TRAF2 and CARD11 produce molecules with significantly enhanced ability to activate NF-kappaB. Thus, our results demonstrate that NF-kappaB activation in DLBCL is caused by genetic lesions affecting multiple genes, the loss or activation of which may promote lymphomagenesis by leading to abnormally prolonged NF-kappaB responses.

PubMed Disclaimer

Figures

Figure 1
Figure 1. The NF-kB pathway is active in ABC-DLBCL and in a smaller fraction of GCB-DLBCL
a) Immunohistochemical staining of DLBCL biopsies with anti-NFKB1(p105/p50)(top) and anti-NFKB2(p100/p52)(bottom) antibodies. Nuclear localization of NF-kB denotes active signaling, as opposed to the inactive, cytoplasmic complex (200X). b) Prevalence of cases displaying constitutive NF-kB activation in DLBCL subgroups. Color codes indicate nuclear p50, p52 or both. c) Western blot analysis of DLBCL cell lines for processing of p100 to p52 (red, ABC-DLBCL; grey, GCB-DLBCL). The multiple myeloma cell line U266 and the epithelial cell line COS are used as positive and negative controls, respectively. Actin, loading control. d) GSEA enrichment score and distribution of NF-kB target genes along the rank of transcripts differentially expressed in ABC- vs GCB-DLBCL. e) Percentage of samples showing a transcriptional NF-kB signature by GSEA. f) Venn diagram illustrating the overlap between immunohistochemistry-defined and GSEA-defined NF-kB positive cases.
Figure 2
Figure 2. Mutations and deletions of the A20 gene in ABC-DLBCL
a) Percentage of A20 mutated cases in various DLBCL subtypes. The exact number over total analyzed is given on top. NC, samples co-expressing CD10 and IRF4 (see Methods). b) Schematic representation of the human A20 protein, with its key functional domains. Color-coded symbols depict distinct alterations leading to A20 inactivation. OTU, ovarian tumor domain; ZF, A-20 zinc-finger domains. c) Dual-color FISH analysis of representative DLBCLs, hybridized with A20-specific probes (red) and a chromosome 6 centromeric probe (green). Arrows point to representative cells displaying hemizygous (left panel) or homozygous (right panel) A20 deletions. d) Chromosome 6 ideogram; the region encompassing A20 on band 6q23 is enlarged in the bottom panel, where columns represent individual cases, and rows correspond to the two alleles. e) Overall frequency of A20 structural alterations (inactivating mutations and deletions, combined).
Figure 3
Figure 3. Reconstitution of A20-null cell lines causes apoptosis and cell growth arrest via inhibition of NF-kB
a, Flow cytometric analysis of AnnexinV-PE/7AAD staining in A20-null and wild-type cell lines, transduced with the indicated vectors; numbers indicate the percentage of single and double-positive cells (lower and upper right quadrants). The results of 3 independent experiments are summarized in panel b (mean ± SD). c, Reduced viability in SUDHL2 cells complemented with A20 expression-vectors (red bars), as compared to vector alone (black bars)(mean±SD, n=3). No effect was observed in two control cell lines. d, Analysis of GFP expression after transduction with pWPI and pWPI-HA-A20 documents the disappearance of the GFP+ population in SUDHL2HA-A20 and RC-K8HA-A20, but not in SUDHL2pWPI and RC-K8pWPI or in A20 wild-type cell lines (mean ± SD, n=2). e) Immunofluorescence analysis of p105/p50 in SUDHL2 cells transduced with pWPI and pWPI-HA-A20 (top). Nuclei are identified by DAPI (bottom).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alizadeh AA, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–11. - PubMed
    1. Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med. 2001;194:1861–74. - PMC - PubMed
    1. Lenz G, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008;319:1676–9. - PubMed
    1. Monti S, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood. 2005;105:1851–61. - PubMed
    1. Savage KJ, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871–9. - PubMed

Publication types

MeSH terms

Substances

Associated data

-